English | Spanish
ecancer
Login Register
The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1488]
News [3589]
Articles [289]
Editorials [9]
Conferences [70]
elearning [23]
Nanostructures with improved stability for the development of more effective cancer nanomedicine
Nanostructures with improved stability for the development of more effective cancer nanomedicine
Particles released by red blood cells are effective carriers for anti-cancer immunotherapy
Particles released by red blood cells are effective carriers for anti-cancer immunotherapy
Gene change explains chemo resistance in germ cell cancer
Gene change explains chemo resistance in germ cell cancer
Tumours change their metabolism to spread more effectively
Tumours change their metabolism to spread more effectively
Cancer-fighting viruses soften up their victims before attacking
Cancer-fighting viruses soften up their victims before attacking
AACR 2022: AURORA study identifies molecular features tied to breast cancer tumour spread
AACR 2022: AURORA study identifies molecular features tied to breast cancer tumour spread
AACR 2022: Recurrent non-invasive breast tumours may not always be related to the primary lesion
AACR 2022: Recurrent non-invasive breast tumours may not always be related to the primary lesion
AACR 2022: Next-generation PARP1-selective inhibitor demonstrates promising clinical activity with a favourable safety profile
AACR 2022: Next-generation PARP1-selective inhibitor demonstrates promising clinical activity with a...
AACR 2022: Expansion trial of ATR inhibitor shows encouraging clinical activity against DDR defects
AACR 2022: Expansion trial of ATR inhibitor shows encouraging clinical activity against DDR defects
Evidence in mice that bacteria in tumours help cancer cells metastasise
Evidence in mice that bacteria in tumours help cancer cells metastasise
<12345...359>

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2022 ecancer, all rights reserved
UK registered charity number: 1176307